Lisa Sudmeier, MD, PhD
-
RoleRadiation Oncology
-
Specialty
-
Research Program
-
Practicing Since2022
Background
As a radiation oncologist, Dr. Sudmeier treats patients with brain and spinal tumors at Emory University Hospital. (Clifton campus)
Dr. Sudmeier received her BA in biology from Washington University in St. Louis, Missouri. She earned her MD and her PhD in neuroscience from University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin. She completed an internship in internal medicine and a radiation oncology residency, where she was chief resident in her final year, at Emory University School of Medicine in Atlanta, Georgia. During residency training, she also completed a research fellowship in cancer immunology with Dr. Rafi Ahmed of the Emory Vaccine Center.
Dr. Sudmeier has been published in numerous scientific journals including Cell Reports Medicine, STAR Protocols, Current Treatment Options in Oncology, Translational Lung Cancer Research, and Disease Models and Mechanisms. She is an ad hoc reviewer for Journal of Immunotherapy of Cancer, Cancer Medicine, International Journal of Radiation Biology, and Neurosurgery.
The goal of Dr. Sudmeiers work is to develop improved treatments for brain metastases and primary brain tumors, with a focus on immunotherapies. Her research program aims to understand the interplay between the unique immune microenvironment of the brain and the immune cells infiltrating tumors growing in the brain and to determine how the biology of these immune cells is affected by different cancer treatments.
Titles & Roles
-
Assistant Professor, Department of Radiation OncologyEmory University School of Medicine
Education & Training
Education
- Residency, Radiation Oncology, 2022Emory University Hospital
- Internship, Internal Medicine, 2018Emory University Hospital
- Medical Education, , 2017University of Wisconsin School of Medicine and Public Health
Professional Memberships
- American Society of Clinical Oncology
- American Board of Radiology
- American Society for Radiation Oncology
- American Association for Women in Radiology
- Society for Immunotherapy of Cancer
- Society for Neuro-Oncology
- Radiation Research Society
|
| Title/Journal | Authors | Publication Date |
|---|---|---|
|
Total scalp irradiation: A study comparing multiple types of bolus and VMAT optimization techniques. Journal of applied clinical medical physics |
TM Davis, K Luca, LJ Sudmeier, ZS Buchwald, MK Khan, X Yang, E Schreibmann, J Zhang, J Roper | 01/04/2024 |
|
Pediatric blood & cancer |
C Williamson, S Williamson, R Jiang, L Sudmeier, N Esiashvili, BR Eaton | 01/01/2024 |
|
Cancer immunology research |
C Alvarez-Breckenridge, KG Anderson, AL Correia, S Demehri, HQ Dinh, KO Dixon, GP Dunn, L Evgin, J Goc, Z Good, N Hacohen, P Han, P Hanč, J Hickey, K Kersten, BC Liu, A Buque, Y' Miao, JJ Milner, Y Pritykin, F Pucci, NE Scharping, L Sudmeier, Y Wang, A Wieland, MM Williams | 01/12/2023 |
|
Cancers |
SS Mannam, DP Bray, CD Nwagwu, J Zhong, HK Shu, B Eaton, L Sudmeier, S Goyal, C Deibert, EK Nduom, J Olson, KB Hoang | 28/09/2023 |
|
Immune microenvironment remodeling after radiation of a progressing brain metastasis. Cell reports. Medicine |
WH Hudson, JJ Olson, LJ Sudmeier | 20/06/2023 |
|
Pediatric blood & cancer |
LJ Sudmeier, N Madden, C Zhang, K Brock, N Esiashvili, BR Eaton | 01/04/2023 |
|
Localization of T cell clonotypes using the Visium spatial transcriptomics platform. STAR protocols |
WH Hudson, LJ Sudmeier | 17/06/2022 |
|
Cell reports. Medicine |
LJ Sudmeier, KB Hoang, EK Nduom, A Wieland, SG Neill, MJ Schniederjan, SS Ramalingam, JJ Olson, R Ahmed, WH Hudson | 17/05/2022 |
Ratings & Reviews
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.
| 4.9 |
| Provider showed concern |
| 4.9 |
| Provider explained things clearly |
| 4.8 |
| Provider discussed treatment options |
| 4.8 |
| Provider included you in decisions |
| 4.8 |
| Likelihood of recommending this provider |
|
15/02/2024 |
Dr. Sudemier showed genuine concern and answered all of my questions, including those raised on my chart. |
|
30/01/2024 |
Very caring and concerned. |
|
11/01/2024 |
Dr. Sudmeier was the "doctor of the day". She introduced herself and explained why I was not seeing my primary Rad Onc Doc. She discussed my treatment plan and answered all of my questions. She is a very competent and caring physician. You are lucky to have her. |
|
25/05/2023 |
Very good |
|
05/04/2023 |
Very Good Experience |
|
04/12/2022 |
Emory is a great place for care |